Zi Michael Miao

11PUBLICATIONS
87CO-AUTHORS
Respiratory diseasesMolecular targetsGene and molecular therapyCardiology (incl. cardiovascular diseases)Epidemiological modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Apr 11, 2026
Effects of Finerenone Across a Range of Heart Failure Duration: A Prespecified Analysis of the FINEARTS-HF Trial.

Yasuhiro Hamatani, John W Ostrominski, Henri Lu

|Nov 20, 2024
Sodium-glucose co-transporter 2 inhibitors and new-onset diabetes in cardiovascular or kidney disease.

John W Ostrominski, Mats C Højbjerg Lassen, Brian L Claggett

|Sep 28, 2024
Effects of the Nonsteroidal MRA Finerenone With and Without Concomitant SGLT2 Inhibitor Use in Heart Failure.

Muthiah Vaduganathan, Brian L Claggett, Ian J Kulac

|Jul 26, 2024
Dosing and Safety Profile of Aficamten in Symptomatic Obstructive Hypertrophic Cardiomyopathy: Results From SEQUOIA-HCM.

Caroline J Coats, Ahmad Masri, Michael E Nassif

|Oct 13, 2023
Dapagliflozin and Apparent Treatment-Resistant Hypertension in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: The DELIVER Trial.

John W Ostrominski, Muthiah Vaduganathan, Senthil Selvaraj

|May 23, 2023
Dapagliflozin and diuretic utilization in heart failure with mildly reduced or preserved ejection fraction: the DELIVER trial.

Safia Chatur, Muthiah Vaduganathan, Brian Claggett

Pageof 2

Frequent Collaborators

8 joint publications

Scott D Solomon

6 joint publications

Muthiah Vaduganathan

6 joint publications

John J V McMurray

6 joint publications

Brian L Claggett